DNA Repair Inhibition as a possible strategy to fight leukemia

This press release is dedicated to the paper I published on Nature Medicine, describing a pre-clinical study about the usage of a new candidate drug on subjects affected by acute myeloid leukemia (AML), and patients affected by aggressive myeloid/lymphoid leukemiae (MLL).
Reference: Esposito, M.T., Zhao, L., Fung, T.K., Rane, J.K., Wilson, A., Martin, N., Gil, J., Leung, A.Y., Ashworth, A., and Eric So, C.W. (2015). Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors. Nature medicine.

About the Author

Maria Teresa Esposito
Maria Teresa Esposito is Postdoctoral Research Assistant at King's College, London, focusing on Hematology and Stem Cells.

Be the first to comment on "DNA Repair Inhibition as a possible strategy to fight leukemia"

Leave a comment

Your email address will not be published.